More articles from Molecular and Cellular Biology, Genetics

Abstract LB-327: Restoration of MYC-repressed miR-29 in pancreatic cancer cells leads to increased reactive oxygen species and gemcitabine sensitization
Jason J. Kwon, Kayla Quirin, Arafat Aljoufi, Amira Nafiseh, Janaiah Kota

Cancer Research Jul 2017, 77 (13 Supplement) LB-327; DOI: 10.1158/1538-7445.AM2017-LB-327
Abstract LB-334: xCT promotes malignant phenotypes in EGFR-expressing glioma
Kenji Tsuchihashi, Shogo Okazaki, Momoko Yoshikawa, Ryo Seishima, Oltea Sampetrean, Nobuyuki Onishi, Hiroaki Wakimoto, Frank Furnari, Eishi Baba, Koichi Akashi, Hideyuki Saya, Osamu Nagano

Cancer Research Jul 2017, 77 (13 Supplement) LB-334; DOI: 10.1158/1538-7445.AM2017-LB-334
Abstract LB-281: Meta analysis of gene transcripts from fatty livers and liver cancers of C57BL6 mice identifies potential drivers of HCC
Kumiko Kato-Shoji, Noriyuki Miyoshi, Miki Igarashi, John I. Risinger, Yutaka Shoji

Cancer Research Jul 2017, 77 (13 Supplement) LB-281; DOI: 10.1158/1538-7445.AM2017-LB-281
Abstract LB-280: The landscape of somatic microsatellite indels across cancer: detection and identification of driver events
Yosef E. Maruvka, Kent W. Mouw, Rosa Karlic, Rasanna Parasuraman, Atanas Kamburov, Paz Polak, Nicholas J. Haradhvala, Julian M. Hess, Esther Rheinbay, Yehuda Brody, Lior Z. Braunstein, Alan D’Andrea, Michael S. Lawrence, Adam Bass, Andre Bernards, Franziska Michor, Gad Getz

Cancer Research Jul 2017, 77 (13 Supplement) LB-280; DOI: 10.1158/1538-7445.AM2017-LB-280
Abstract LB-263: P53 promotes replication genome stability by epigenetics-enabled MRE11 restart
Katharina Schlacher, Sunetra Roy, Karl-Heinz Tomaszowski

Cancer Research Jul 2017, 77 (13 Supplement) LB-263; DOI: 10.1158/1538-7445.AM2017-LB-263
Abstract LB-278: Whole exome sequencing of metaplastic breast carcinoma indicates monoclonality with associated ductal carcinoma component
Bracha E. Avigdor, Katie Beierl, Christopher D. Gocke, Daniel J. Zabransky, Karen Cravero, Kelly Kyker-Snowmana, Berry Button, David Chu, Sarah Croessmann, Rory L. Cochran, Roisin M. Connolly, Ben H. Park, Ashley Cimino-Mathews, Sarah J. Wheelan

Cancer Research Jul 2017, 77 (13 Supplement) LB-278; DOI: 10.1158/1538-7445.AM2017-LB-278
Abstract LB-277: Four noval activating and resistance mutations of EGFR drug response targets were discovered in northern Chinese patients
Geng Tian

Cancer Research Jul 2017, 77 (13 Supplement) LB-277; DOI: 10.1158/1538-7445.AM2017-LB-277
Abstract LB-324: Methylation-associated silencing of miR-193a-3p promotes ovarian cancer aggressiveness via targeting GRB7
Kangmei Chen, Hextan YS Ngan, David W. Chan

Cancer Research Jul 2017, 77 (13 Supplement) LB-324; DOI: 10.1158/1538-7445.AM2017-LB-324
Abstract LB-328: Mir-520b as a novel molecular target for suppressing stemness phenotype of head-neck cancer by inhibiting CD44
Ann-Joy Cheng, Ya-Ching Lu, Joseph T. Chang

Cancer Research Jul 2017, 77 (13 Supplement) LB-328; DOI: 10.1158/1538-7445.AM2017-LB-328
Abstract LB-323: Comparative miRNA microarray profiling indicates miR-363 promotes chemoresistance in ovarian cancer cells by targeting the Hippo member, LATS2
Noriaki Sakuragi, Mohamed Kamel Farah, Zeinab Mohamed, Safwat Okasha, Hidemichi Watari, Takashi Mitamura, sherif El Khamisy, Yusuke Ohba

Cancer Research Jul 2017, 77 (13 Supplement) LB-323; DOI: 10.1158/1538-7445.AM2017-LB-323

Main menu

User menu

Search

More articles from Molecular and Cellular Biology, Genetics

Pages

Articles

Info for

About Cancer Research